Tue, January 16, 2018
Fri, January 12, 2018
Thu, January 11, 2018
Wed, January 10, 2018
Tue, January 9, 2018
Mon, January 8, 2018
Fri, January 5, 2018
Thu, January 4, 2018
Wed, January 3, 2018
Tue, January 2, 2018
Tue, December 26, 2017
Fri, December 22, 2017
Thu, December 21, 2017
Wed, December 20, 2017
Tue, December 19, 2017
Mon, December 18, 2017
Fri, December 15, 2017
Thu, December 14, 2017
Wed, December 13, 2017
Tue, December 12, 2017
Mon, December 11, 2017
Fri, December 8, 2017
Thu, December 7, 2017
Wed, December 6, 2017
Tue, December 5, 2017

Debjit Chattopadhyay Initiated (BOLD) at Strong Buy and Held Target at $37 on, Dec 20th, 2017


//stocks-investing.news-articles.net/content/201 .. -buy-and-held-target-at-37-on-dec-20th-2017.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Debjit Chattopadhyay of HC Wainwright & Co., Initiated "Boundless Bio, Inc." (BOLD) at Strong Buy and Held Target at $37 on, Dec 20th, 2017.

Debjit has made no other calls on BOLD in the last 4 months.



There are 5 other peers that have a rating on BOLD. Out of the 5 peers that are also analyzing BOLD, 2 agree with Debjit's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Josh Schimmer of "Evercore ISI Group" Downgraded from Buy to Hold on, Monday, October 16th, 2017
  • Reni Benjamin of "Raymond James" Initiated at Hold on, Thursday, October 12th, 2017


These are the ratings of the 3 analyists that currently disagree with Debjit


  • Matthew Luchini of "BMO Capital" Initiated at Buy and Held Target at $35 on, Tuesday, December 5th, 2017
  • Raju Prasad of "William Blair" Initiated at Buy and Held Target at $35 on, Tuesday, October 17th, 2017
  • Ying Huang of "B of A Securities" Maintained at Strong Buy with Increased Target to $33 on, Friday, September 22nd, 2017

Publication Contributing Sources